Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell surface glycoprotein CD3 epsilon is a transmembrane protein that is an essential component of the CD3 complex, which, together with the T cell receptor (TCR) α/β or γ/δ heterodimers, forms the TCR–CD3 complex critical for T cell development, activation, and immune signaling[3][4][7]. CD3ε is found in two distinct heterodimers (CD3γε and CD3δε) that noncovalently assemble with TCR on the T cell surface[4][7]. Its cytoplasmic tail contains immunoreceptor tyrosine-based activation motifs (ITAMs), which are phosphorylated upon antigen engagement, initiating downstream signaling needed for T cell immune functions[1][3]. CD3ε can be targeted therapeutically by specific monoclonal antibodies, relevant in autoimmune diseases, transplant rejection, and T cell malignancies[2][3]. It also serves as a robust biomarker for the identification of T cells in clinical and research settings.
Monoclonal antibodies targeting CD3ε can modulate T cell activation, leading to either depletion of T cells, immune suppression/tolerance induction, or immunomodulation depending on the context and dosing[2][3].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell surface glycoprotein CD3 epsilon (CD3ε).